Factors influencing adherence in Hepatitis-C infected patients: a systematic review
- PMID: 24731285
- PMCID: PMC4021290
- DOI: 10.1186/1471-2334-14-203
Factors influencing adherence in Hepatitis-C infected patients: a systematic review
Abstract
Background: Adherence is a crucial point for the successful treatment of a hepatitis-C virus infection. Studies have shown that especially adherence to ribavirin is important.The objective of this systematic review was to identify factors that influence adherence in hepatitis-C infected patients taking regimes that containing ribavirin.
Methods: A systematic literature search was performed in Medline and Embase in March 2014 without limits for publication date. Titles and abstracts and in case of relevance, full-texts were screened according to predefined inclusion criteria. The risk of bias was assessed. Both process steps were carried out independently by two reviewers. Relevant data on study characteristics and results were extracted in standardized tables by one reviewer and checked by a second. Data were synthesized in a narrative way using a standardized procedure.
Results: Nine relevant studies were identified. The number of analyzed patients ranged between 12 and 5706 patients. The study quality was moderate. Especially the risk of bias regarding the measurement of influencing factors was mostly unclear."Psychiatric disorders" (N = 5) and having to take "higher doses of ribavirin" (N = 3) showed a negative influence on adherence. In contrast, a "HIV co-infection" (N = 2) and the "hemoglobin level" (N = 2) were associated with a positive influence on adherence. Furthermore, there is the tendency that male patients are more adherent than female patients (N = 6). "Alcohol consumption" (N = 2), "education", "employment status", "ethnic group","hepatitis-C virus RNA" (N = 4), "genotype" (N = 5), "metavir activity" (N = 1) and "weight" (N = 3) showed mostly no effect on adherence. Although, some studies showed statistically significant results for "age", "drug use" , "genotype", "medication dose interferon", and "treatment experience" the effect is unclear because effect directions were partly conflicting.The other factors were heterogeneous regarding the effect direction and/or statistical significance.
Conclusion: There are some factors that seem to show an influence on adherence. However, due to the heterogeneity (e.g. patient characteristics, regimes, settings, countries) no general conclusions can be made. The results should rather be considered as indications for factors that can have an influence on adherence in hepatitis-C infected patients taking regimes that containing ribavirin.
Figures
Similar articles
-
Adherence influencing factors in patients taking oral anticancer agents: a systematic review.Cancer Epidemiol. 2014 Jun;38(3):214-26. doi: 10.1016/j.canep.2014.03.012. Epub 2014 Apr 24. Cancer Epidemiol. 2014. PMID: 24768601
-
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170. Health Technol Assess. 2011. PMID: 21473834 Free PMC article.
-
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.Cochrane Database Syst Rev. 2014 Jun 17;2014(6):CD011132. doi: 10.1002/14651858.CD011132.pub2. Cochrane Database Syst Rev. 2014. PMID: 24937404 Free PMC article.
-
Aminoadamantanes for chronic hepatitis C.Cochrane Database Syst Rev. 2014 May 3;2014(5):CD010125. doi: 10.1002/14651858.CD010125.pub2. Cochrane Database Syst Rev. 2014. PMID: 24793264 Free PMC article.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
Cited by
-
Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects.Front Psychol. 2019 Oct 15;10:2317. doi: 10.3389/fpsyg.2019.02317. eCollection 2019. Front Psychol. 2019. PMID: 31681109 Free PMC article.
-
The analysis of factors affecting medication adherence in patients with myasthenia gravis: a cross-sectional study.Ther Adv Neurol Disord. 2024 Apr 22;17:17562864231206877. doi: 10.1177/17562864231206877. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38654744 Free PMC article.
-
Medication adherence influencing factors-an (updated) overview of systematic reviews.Syst Rev. 2019 May 10;8(1):112. doi: 10.1186/s13643-019-1014-8. Syst Rev. 2019. PMID: 31077247 Free PMC article.
-
Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy.Front Pharmacol. 2020 Nov 13;11:551500. doi: 10.3389/fphar.2020.551500. eCollection 2020. Front Pharmacol. 2020. PMID: 33364936 Free PMC article.
-
Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.Lancet Glob Health. 2021 Apr;9(4):e431-e445. doi: 10.1016/S2214-109X(20)30505-2. Epub 2021 Feb 24. Lancet Glob Health. 2021. PMID: 33639097 Free PMC article.
References
-
- Sharma P, Marrero JA, Fontana RJ, Greenson JK, Conjeevaram H, Su GL, Askari F, Sullivan P, Lok AS. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl. 2007;14:1100–1108. doi: 10.1002/lt.21121. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical